INTERNATIONAL PATENT: ARO BIOTHERAPEUTICS COMPANY FILES APPLICATION FOR "FORMULATIONS COMPRISING FN3-SIRNA CONJUGATES AND USES THEREOF"

GENEVA, Dec. 2 -- ARO BIOTHERAPEUTICS COMPANY (601 Walnut Street, Suite 740Philadelphia, Pennsylvania 19106) filed a patent application (PCT/US2025/030821) for "FORMULATIONS COMPRISING FN3-SIRNA CONJUGATES AND USES THEREOF" on May 23, 2025. With publication no. WO/2025/245474, the details related to the patent application was published on Nov 27, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): GOLDSTEIN, Josh (c/o ARO Biotherapeutics Company601 Walnut Street, Suite 740Philadelphia, Pennsylvania 19106), DINERMAN, Adam (c/o ARO Biotherapeutics Company601 Walnut Street, Suite 740Philadelphia, P...